Impact of Treatment Adherence on Efficacy of Dolutegravir + Lamivudine and Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Week 144 Analysis of the GEMINI-1 and GEMINI-2 Clinical Studies

J Acquir Immune Defic Syndr. 2023 Nov 1;94(3):e9-e12. doi: 10.1097/QAI.0000000000003280.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • Emtricitabine / therapeutic use
  • HIV Infections* / drug therapy
  • Heterocyclic Compounds, 3-Ring / therapeutic use
  • Humans
  • Lamivudine / therapeutic use
  • Oxazines / therapeutic use
  • Pyridones / therapeutic use
  • Tenofovir / therapeutic use
  • Treatment Adherence and Compliance

Substances

  • Lamivudine
  • Tenofovir
  • Emtricitabine
  • dolutegravir
  • Oxazines
  • Heterocyclic Compounds, 3-Ring
  • Pyridones
  • Anti-HIV Agents